HLA-DO
| major histocompatibility complex, class II, DO alpha | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | HLA-DOA | ||||||
| Alt. symbols | HLA-DZA, HLA-DNA | ||||||
| NCBI gene | 3111 | ||||||
| HGNC | 4936 | ||||||
| OMIM | 142930 | ||||||
| RefSeq | NM_002119 | ||||||
| UniProt | Q9TQD3 | ||||||
| Other data | |||||||
| Locus | Chr. 6 p21.3 | ||||||
| |||||||
| major histocompatibility complex, class II, DO beta | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | HLA-DOB | ||||||
| NCBI gene | 3112 | ||||||
| HGNC | 4937 | ||||||
| OMIM | 600629 | ||||||
| RefSeq | NM_002120 | ||||||
| UniProt | P13765 | ||||||
| Other data | |||||||
| Locus | Chr. 6 p21.3 | ||||||
| |||||||
HLA-DO is a dimeric MHC class II protein composed of α- and β-subunits which assists in the down-regulation of HLA-DM.[1]
References
- ^ Fallas JL, Tobin HM, Lou O, Guo D, Sant'Angelo DB, Denzin LK (August 2004). "Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation". J. Immunol. 173 (3): 1549–60. doi:10.4049/jimmunol.173.3.1549. PMID 15265882.
{{cite journal}}: CS1 maint: multiple names: authors list (link)
 | This immunology article is a stub. You can help Wikipedia by expanding it. |
a